Search Within

Adult Leukemia

Formats
  1. Meeting Abstract (1797)
  2. Journal Article (1603)
  3. Review (122)
  4. Research Letter (55)
  5. Editorial (49)
  6. Book Section (39)
  7. Guidelines (20)
  8. Conference Paper (18)
  9. Correspondence (13)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3720)
  2. Department of Medicine (3689)
  3. Hematologic Malignancies, Division of (3685)
  4. GSK Faculty (1783)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (1378)
  6. Executive Committee, Center for Hematologic Malignancies (970)

More Groups

People
  1. Ross Levine (787)
  2. Martin Tallman (655)
  3. David Scheinberg (502)
  4. Jae Park (387)
  5. Eytan Stein (371)
  6. Raajit Rampal (352)

More People

Years
  1. 2025 (103)
  2. 2024 (196)
  3. 2023 (233)
  4. 2022 (255)
  5. 2021 (248)
  6. 2020 (273)

More Years

Publications
  1. Blood (1254)
  2. Journal of Clinical Oncology (217)
  3. Clinical Lymphoma, Myeloma and Leukemia (117)
  4. Leukemia (110)
  5. Haematologica (107)
  6. Cancer Research (86)

More Publications

Publishers
  1. American Society of Hematology (1345)
  2. Nature Publishing Group (324)
  3. Elsevier Inc. (255)
  4. American Association for Cancer Research (234)
  5. American Society of Clinical Oncology (230)
  6. Ferrata Storti Foundation (107)

More Publishers

Results (3720)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Alpha particle radiobiology and the treatment of prostate adenocarcinoma
    Meeting Abstract

    Mello, B. P.; Revskaya, E.; Scheinberg, D. A.; McDevitt, M. R.
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Clinical benefit of pelabresib (CPI-0610) in combination with ruxolitinib in JAK inhibitor treatment-naìˆve myelofibrosis patients: Interim efficacy subgroup analysis from Arm 3 of the MANIFEST phase 2 study
    Meeting Abstract

    Gupta, V.; Kremyanskaya, M.; Mascarenhas, J.; Palandri, F.; Patriarca, A.; Devos, T.; Harrison, C.; Passamonti, F.; Rampal, R.; Mead, A.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  • KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: Phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study
    Journal Article

    Shah, B. D.; Ghobadi, A.; Oluwole, O. O.; Logan, A. C.; Boissel, N.; Cassaday, R. D.; Leguay, T.; Bishop, M. R.; Topp, M. S.; Tzachanis, D.; more...
    Lancet (2021)

    Fulltext@MSK | Save
  • Universal engraftment after allogeneic hematopoietic cell transplantation using cryopreserved CD34-selected grafts
    Journal Article

    Jacob, R. P.; Flynn, J.; Devlin, S. M.; Maloy, M.; Giralt, S. A.; Maslak, P.; O'Reilly, R. J.; Tonon, J. A.; Perales, M. A.; Avecilla, S. T.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • Streamlined operational approaches and use of e-technologies in clinical trials: Beat acute myeloid leukemia master trial
    Journal Article

    Rosenberg, L.; Levaux, H.; Levine, R. L.; Shah, A.; Denmark, J.; Hereema, N.; Owen, M.; Kalk, S.; Kenny, N.; Vinson, G.; more...
    Therapeutic Innovation & Regulatory Science (2021)

    Fulltext@MSK | Save
  • Searching for a home: Phosphoinositide 3-kinase inhibitors for chronic lymphocytic leukaemia in modern clinical practice
    Editorial

    Roeker, L. E.; Thompson, M. C.; Mato, A. R.
    British Journal of Haematology (2021)

    Fulltext@MSK | Save
  • Machine learning and artificial intelligence in neurosurgery: Status, prospects, and challenges
    Editorial

    Dagi, T. F.; Barker, F. G. 2nd; Glass, J.
    Neurosurgery (2021)

    Fulltext@MSK | Save
  • Neutropenia in adult acute myeloid leukemia patients represents a powerful risk factor for COVID-19 related mortality
    Journal Article

    Stahl, M.; Narendra, V.; Jee, J.; Derkach, A.; Maloy, M.; Geyer, M. B.; Mato, A. R.; Roeker, L. E.; Tallman, M. S.; Shah, G. L.; more...
    Leukemia and Lymphoma (2021)

    Fulltext@MSK | Save
  • Hairy cell leukemia masquerading as CD5+ lymphoproliferative disease: The importance of BRAF V600E testing in diagnosis and treatment
    Journal Article

    Soong, D.; Kumar, P.; Jatwani, K.; Park, J.; Dogan, A.; Taylor, J.
    JCO Precision Oncology (2021)

    Fulltext@MSK | Save
  • The promised land
    Editorial

    Stein, E. M.
    Haematologica (2021)

    Fulltext@MSK | Save